IKKbeta specifically binds to P16 and phosphorylates Ser8 of P16

Yi Guo1, Chunhua Yuan, Christopher M Weghorst

  • 1Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210, USA.

Insights

The study identifies IKKbeta as a novel kinase that phosphorylates P16 (also known as cyclin-dependent kinase inhibitor 2A) at Ser8. This phosphorylation significantly reduces P16

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Posttranslational regulation of P16 (INK4A/MTS1), a key regulator of cell cycle progression, senescence, and aging, is not fully understood.
  • Previous studies indicated P16 phosphorylation at Ser7, Ser8, Ser140, and Ser152, but the responsible kinases were unidentified.

Purpose of the Study:

  • To identify the kinase responsible for P16 phosphorylation.
  • To investigate the functional consequences of P16 phosphorylation at specific serine residues.

Main Methods:

  • Immunoprecipitation assays to detect protein-protein interactions.
  • Kinase assays to confirm enzymatic activity.
  • Biochemical characterization of phosphomimetic P16 mutants (Ser-->Glu).

Main Results:

  • IKKbeta, a known kinase for IkappaBalpha, was found to specifically bind and phosphorylate P16 at Ser8 in WI38 cells.
  • Phosphorylation at Ser8 (mimicked by Ser8Glu mutation) significantly diminished P16's inhibitory activity towards cyclin-dependent kinase (CDK) 4.
  • Phosphorylation at Ser7, Ser140, and Ser152 did not affect P16's structure or function.

Conclusions:

  • IKKbeta plays a novel role in the posttranslational regulation of P16.
  • Phosphorylation of P16 at Ser8 by IKKbeta is a critical regulatory mechanism that modulates its CDK4 inhibitory function.
  • This finding expands the understanding of P16 regulation in cellular processes like aging and senescence.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...